한글목차

세계 무혈청세포 동결보존 배지 시장 규모는 2024년 2억 4,305만 달러에 달했습니다.

이 시장은 2031년에는 4억 653만 달러에 달할 것이며, 2025년부터 2031년까지 연평균 8.05%의 성장률을 기록할 것으로 예상됩니다.

이 보고서는 전 세계 무혈청세포 동결보존배지 시장을 포괄적으로 소개하며, 무혈청세포 동결보존배지의 지역별, 국가별, 유형별, 용도별 분석과 함께 총 판매량, 판매 수익, 가격, 주요 기업의 시장 점유율 및 순위에 초점을 맞추고 있습니다.

무혈청세포 동결보존 배지의 시장 규모 예측은 2024년을 기준 연도로 하여 2020년부터 2031년까지의 과거 데이터와 예측 데이터를 판매량 및 판매 수익으로 제공하고 있습니다. 정량적 및 정성적 분석을 통해 독자가 비즈니스/성장 전략을 수립하고, 시장 경쟁 상황을 평가하고, 현재 시장에서의 위치를 분석하고, 무혈청세포 동결보존 배지에 대한 정보에 입각한 비즈니스 의사결정을 내리는 데 도움이 될 것입니다.

목차

제1장 시장 개요

• 무혈청세포 동결보존 배지 제품 소개
• 세계의 무혈청세포 동결보존 배지 시장 규모 예측
• 무혈청세포 동결보존 배지 시장 동향과 촉진요인
• 가정과 제한
• 조사 목적
• 대상 연도

제2장 기업에 의한 경쟁 분석

제3장 유형별 세분화

• 유형별 소개
• 세계의 무혈청세포 동결보존 배지 판매액, 유형별
• 세계의 무혈청세포 동결보존 배지 판매량, 유형별
• 세계의 무혈청세포 동결보존 배지 평균 가격, 유형별(2020-2031년)

제4장 용도별 세분화

• 용도별 소개
• 세계의 무혈청세포 동결보존 배지 판매액, 용도별
• 세계의 무혈청세포 동결보존 배지 판매량, 용도별
• 세계의 무혈청세포 동결보존 배지 평균 가격, 용도별(2020-2031년)

제5장 지역별 세분화

• 세계의 무혈청세포 동결보존 배지 판매액, 지역별
• 세계의 무혈청세포 동결보존 배지 판매량, 지역별
• 세계의 무혈청세포 동결보존 배지 평균 가격, 지역별(2020-2031년)
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제6장 주요 국가·지역별 세분화

• 주요 국가/지역별 무혈청세포 동결보존 배지 판매액 성장 동향, 2020년 대 2024년 대 2031년
• 주요 국가/지역별 무혈청세포 동결보존 배지 판매액
• 북미
• 유럽
• 중국
• 일본
• 한국
• 동남아시아
• 인도

제7장 기업 개요

• Thermo Fisher
• Merck
• Zenoaq
• STEMCELL
• Cytiva
• BioLifeSolutions
• Fujifilm
• Lonza
• Sartorius(Biological Industries)
• Nippon Genetics
• HiMedia
• PromoCell

제8장 산업 체인 분석

제9장 조사 결과와 결론

제10장 부록

영문목차

The global Serum-Free Cell Cryopreservation Medium market was valued at US$ 243.05 million in 2024 and is expected to reach US$ 406.53 million by 2031, growing at a CAGR of 8.05% during 2025-2031.

This report aims to provide a comprehensive presentation of the global market for Serum-Free Cell Cryopreservation Medium, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Serum-Free Cell Cryopreservation Medium by region & country, by Type, and by Application.

The Serum-Free Cell Cryopreservation Medium market size, estimations, and forecasts are provided in terms of sales volume (K Liter) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Serum-Free Cell Cryopreservation Medium.

Market Segmentation

By Company

• Thermo Fisher
• Merck
• Zenoaq
• STEMCELL
• Cytiva
• BioLifeSolutions
• Fujifilm
• Lonza
• Sartorius
• Nippon Genetics
• HiMedia
• PromoCell

Segment by Type

• With DMSO
• DMSO-free

Segment by Application

• Pharmaceutical & Biotechnology
• Academic & Research Institutes

By Region

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia-Pacific
• Europe
• Germany
• UK
• France
• Russia
• Italy
• Rest of Europe
• Latin America
• Brazil
• Argentina
• Rest of Latin America
• Middle East & Africa
• Middle East
• Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Serum-Free Cell Cryopreservation Medium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Serum-Free Cell Cryopreservation Medium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Serum-Free Cell Cryopreservation Medium in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Serum-Free Cell Cryopreservation Medium Product Introduction
• 1.2 Global Serum-Free Cell Cryopreservation Medium Market Size Forecast
  • 1.2.1 Global Serum-Free Cell Cryopreservation Medium Sales Value (2020-2031)
  • 1.2.2 Global Serum-Free Cell Cryopreservation Medium Sales Volume (2020-2031)
  • 1.2.3 Global Serum-Free Cell Cryopreservation Medium Sales Price (2020-2031)
• 1.3 Serum-Free Cell Cryopreservation Medium Market Trends & Drivers
  • 1.3.1 Serum-Free Cell Cryopreservation Medium Industry Trends
  • 1.3.2 Serum-Free Cell Cryopreservation Medium Market Drivers & Opportunity
  • 1.3.3 Serum-Free Cell Cryopreservation Medium Market Challenges
  • 1.3.4 Serum-Free Cell Cryopreservation Medium Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Serum-Free Cell Cryopreservation Medium Players Revenue Ranking (2024)
• 2.2 Global Serum-Free Cell Cryopreservation Medium Revenue by Company (2020-2025)
• 2.3 Global Serum-Free Cell Cryopreservation Medium Players Sales Volume Ranking (2024)
• 2.4 Global Serum-Free Cell Cryopreservation Medium Sales Volume by Company Players (2020-2025)
• 2.5 Global Serum-Free Cell Cryopreservation Medium Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Serum-Free Cell Cryopreservation Medium Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Serum-Free Cell Cryopreservation Medium Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Serum-Free Cell Cryopreservation Medium
• 2.9 Serum-Free Cell Cryopreservation Medium Market Competitive Analysis
  • 2.9.1 Serum-Free Cell Cryopreservation Medium Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Serum-Free Cell Cryopreservation Medium Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Serum-Free Cell Cryopreservation Medium as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 With DMSO
  • 3.1.2 DMSO-free
• 3.2 Global Serum-Free Cell Cryopreservation Medium Sales Value by Type
  • 3.2.1 Global Serum-Free Cell Cryopreservation Medium Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Serum-Free Cell Cryopreservation Medium Sales Value, by Type (2020-2031)
  • 3.2.3 Global Serum-Free Cell Cryopreservation Medium Sales Value, by Type (%) (2020-2031)
• 3.3 Global Serum-Free Cell Cryopreservation Medium Sales Volume by Type
  • 3.3.1 Global Serum-Free Cell Cryopreservation Medium Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Serum-Free Cell Cryopreservation Medium Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Serum-Free Cell Cryopreservation Medium Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Serum-Free Cell Cryopreservation Medium Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Pharmaceutical & Biotechnology
  • 4.1.2 Academic & Research Institutes
• 4.2 Global Serum-Free Cell Cryopreservation Medium Sales Value by Application
  • 4.2.1 Global Serum-Free Cell Cryopreservation Medium Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Serum-Free Cell Cryopreservation Medium Sales Value, by Application (2020-2031)
  • 4.2.3 Global Serum-Free Cell Cryopreservation Medium Sales Value, by Application (%) (2020-2031)
• 4.3 Global Serum-Free Cell Cryopreservation Medium Sales Volume by Application
  • 4.3.1 Global Serum-Free Cell Cryopreservation Medium Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Serum-Free Cell Cryopreservation Medium Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Serum-Free Cell Cryopreservation Medium Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Serum-Free Cell Cryopreservation Medium Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Serum-Free Cell Cryopreservation Medium Sales Value by Region
  • 5.1.1 Global Serum-Free Cell Cryopreservation Medium Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Serum-Free Cell Cryopreservation Medium Sales Value by Region (2020-2025)
  • 5.1.3 Global Serum-Free Cell Cryopreservation Medium Sales Value by Region (2026-2031)
  • 5.1.4 Global Serum-Free Cell Cryopreservation Medium Sales Value by Region (%), (2020-2031)
• 5.2 Global Serum-Free Cell Cryopreservation Medium Sales Volume by Region
  • 5.2.1 Global Serum-Free Cell Cryopreservation Medium Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Serum-Free Cell Cryopreservation Medium Sales Volume by Region (2020-2025)
  • 5.2.3 Global Serum-Free Cell Cryopreservation Medium Sales Volume by Region (2026-2031)
  • 5.2.4 Global Serum-Free Cell Cryopreservation Medium Sales Volume by Region (%), (2020-2031)
• 5.3 Global Serum-Free Cell Cryopreservation Medium Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Serum-Free Cell Cryopreservation Medium Sales Value, 2020-2031
  • 5.4.2 North America Serum-Free Cell Cryopreservation Medium Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Serum-Free Cell Cryopreservation Medium Sales Value, 2020-2031
  • 5.5.2 Europe Serum-Free Cell Cryopreservation Medium Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Serum-Free Cell Cryopreservation Medium Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Serum-Free Cell Cryopreservation Medium Sales Value by Region (%), 2024 VS 2031
• 5.7 Latin America
  • 5.7.1 Latin America Serum-Free Cell Cryopreservation Medium Sales Value, 2020-2031
  • 5.7.2 Latin America Serum-Free Cell Cryopreservation Medium Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Serum-Free Cell Cryopreservation Medium Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Serum-Free Cell Cryopreservation Medium Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Serum-Free Cell Cryopreservation Medium Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Serum-Free Cell Cryopreservation Medium Sales Value
  • 6.2.1 Key Countries/Regions Serum-Free Cell Cryopreservation Medium Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Serum-Free Cell Cryopreservation Medium Sales Volume, 2020-2031
• 6.3 North America
  • 6.3.1 North America Serum-Free Cell Cryopreservation Medium Sales Value, 2020-2031
  • 6.3.2 North America Serum-Free Cell Cryopreservation Medium Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 North America Serum-Free Cell Cryopreservation Medium Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Serum-Free Cell Cryopreservation Medium Sales Value, 2020-2031
  • 6.4.2 Europe Serum-Free Cell Cryopreservation Medium Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Serum-Free Cell Cryopreservation Medium Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Serum-Free Cell Cryopreservation Medium Sales Value, 2020-2031
  • 6.5.2 China Serum-Free Cell Cryopreservation Medium Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Serum-Free Cell Cryopreservation Medium Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Serum-Free Cell Cryopreservation Medium Sales Value, 2020-2031
  • 6.6.2 Japan Serum-Free Cell Cryopreservation Medium Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Serum-Free Cell Cryopreservation Medium Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Serum-Free Cell Cryopreservation Medium Sales Value, 2020-2031
  • 6.7.2 South Korea Serum-Free Cell Cryopreservation Medium Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Serum-Free Cell Cryopreservation Medium Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Serum-Free Cell Cryopreservation Medium Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Serum-Free Cell Cryopreservation Medium Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Serum-Free Cell Cryopreservation Medium Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Serum-Free Cell Cryopreservation Medium Sales Value, 2020-2031
  • 6.9.2 India Serum-Free Cell Cryopreservation Medium Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Serum-Free Cell Cryopreservation Medium Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Thermo Fisher
  • 7.1.1 Thermo Fisher Company Information
  • 7.1.2 Thermo Fisher Introduction and Business Overview
  • 7.1.3 Thermo Fisher Serum-Free Cell Cryopreservation Medium Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Thermo Fisher Serum-Free Cell Cryopreservation Medium Product Offerings
• 7.2 Merck
  • 7.2.1 Merck Company Information
  • 7.2.2 Merck Introduction and Business Overview
  • 7.2.3 Merck Serum-Free Cell Cryopreservation Medium Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Merck Serum-Free Cell Cryopreservation Medium Product Offerings
• 7.3 Zenoaq
  • 7.3.1 Zenoaq Company Information
  • 7.3.2 Zenoaq Introduction and Business Overview
  • 7.3.3 Zenoaq Serum-Free Cell Cryopreservation Medium Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Zenoaq Serum-Free Cell Cryopreservation Medium Product Offerings
• 7.4 STEMCELL
  • 7.4.1 STEMCELL Company Information
  • 7.4.2 STEMCELL Introduction and Business Overview
  • 7.4.3 STEMCELL Serum-Free Cell Cryopreservation Medium Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 STEMCELL Serum-Free Cell Cryopreservation Medium Product Offerings
• 7.5 Cytiva
  • 7.5.1 Cytiva Company Information
  • 7.5.2 Cytiva Introduction and Business Overview
  • 7.5.3 Cytiva Serum-Free Cell Cryopreservation Medium Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Cytiva Serum-Free Cell Cryopreservation Medium Product Offerings
• 7.6 BioLifeSolutions
  • 7.6.1 BioLifeSolutions Company Information
  • 7.6.2 BioLifeSolutions Introduction and Business Overview
  • 7.6.3 BioLifeSolutions Serum-Free Cell Cryopreservation Medium Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 BioLifeSolutions Serum-Free Cell Cryopreservation Medium Product Offerings
• 7.7 Fujifilm
  • 7.7.1 Fujifilm Company Information
  • 7.7.2 Fujifilm Introduction and Business Overview
  • 7.7.3 Fujifilm Serum-Free Cell Cryopreservation Medium Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Fujifilm Serum-Free Cell Cryopreservation Medium Product Offerings
• 7.8 Lonza
  • 7.8.1 Lonza Company Information
  • 7.8.2 Lonza Introduction and Business Overview
  • 7.8.3 Lonza Serum-Free Cell Cryopreservation Medium Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Lonza Serum-Free Cell Cryopreservation Medium Product Offerings
• 7.9 Sartorius (Biological Industries)
  • 7.9.1 Biological Industries Company Information
  • 7.9.2 Biological Industries Introduction and Business Overview
  • 7.9.3 Biological Industries Serum-Free Cell Cryopreservation Medium Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 Biological Industries Serum-Free Cell Cryopreservation Medium Product Offerings
• 7.10 Nippon Genetics
  • 7.10.1 Nippon Genetics Company Information
  • 7.10.2 Nippon Genetics Introduction and Business Overview
  • 7.10.3 Nippon Genetics Serum-Free Cell Cryopreservation Medium Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 Nippon Genetics Serum-Free Cell Cryopreservation Medium Product Offerings
• 7.11 HiMedia
  • 7.11.1 HiMedia Company Information
  • 7.11.2 HiMedia Introduction and Business Overview
  • 7.11.3 HiMedia Serum-Free Cell Cryopreservation Medium Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.11.4 HiMedia Serum-Free Cell Cryopreservation Medium Product Offerings
• 7.12 PromoCell
  • 7.12.1 PromoCell Company Information
  • 7.12.2 PromoCell Introduction and Business Overview
  • 7.12.3 PromoCell Serum-Free Cell Cryopreservation Medium Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.12.4 PromoCell Serum-Free Cell Cryopreservation Medium Product Offerings

8 Industry Chain Analysis

• 8.1 Serum-Free Cell Cryopreservation Medium Industrial Chain
• 8.2 Serum-Free Cell Cryopreservation Medium Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Downstream Analysis (Customers Analysis)
• 8.4 Sales Model and Sales Channels
  • 8.4.1 Serum-Free Cell Cryopreservation Medium Sales Model
  • 8.4.2 Sales Channel
  • 8.4.3 Serum-Free Cell Cryopreservation Medium Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
  • 10.1.2 Data Source
• 10.2 Author Details
• 10.3 Disclaimer